Key result
Pharmacologic treatment of fetal tachyarrhythmias currently lacks an evidence-based approach, prompting the proposal of an international registry to guide management.
Highlights the lack of evidence-based management for fetal tachyarrhythmias and proposes an international registry to gather necessary data.
Fetal tachyarrhythmias are a life-threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhythmia type, and timing and duration of treatment. Currently, no evidence-based approach to the management of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence-based management strategies.
No takes yet. Share an insight, caveat, or question.
Heuvel et al. (2008) conducted an editorial in Fetal tachyarrhythmias. Pharmacologic treatment was evaluated. Pharmacologic treatment of fetal tachyarrhythmias currently lacks an evidence-based approach, prompting the proposal of an international registry to guide management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: